Device / Technology News

RSS

First in vivo screening system for complete human nuclear hormone receptor family

The InDanio screening system can be used, for example, to functionally characterize 'orphan' receptors - those for which their natural ligands or specific function are unknown - and thus qualify them as potential targets for drug discovery. The system can also be used to screen compound libraries in order to identify and refine potential new drugs that target NR proteins.

20 Oct 2010

Vivakor enters global licensing agreement with MIT Holding for Vivathermic Vials

Vivakor, Inc. announces today that it has entered into an exclusive licensing agreement with MIT Holding Inc. to manage all distribution of its Vivathermic Vials worldwide. Chairman Matt Nicosia adds the following statement to the news: "This is a great step forward in the distribution of Vivakor technology.

20 Oct 2010

Pharsight launches Phoenix Pharmacometric Productivity Challenge

Pharsight, a market-leading provider of software and scientific consulting services to improve productivity and decision-making in clinical drug development, announced today that it has launched the Phoenix Pharmacometric Productivity Challenge, a competition to recognize excellence in the application of pharmacometric software to critical problems in drug development.

20 Oct 2010

Microsulis tissue ablation systems presented at London meeting

Dr Peter Clegg, from the University of Bath microwave science team, who invented and developed the Microsulis microwave tissue ablation systems for destroying tumours, presented an overview of the success of this technology at the recent 'Changing Worlds Showcase Impact of University Research' meeting held in London.

20 Oct 2010

UTHSC-Houston initiates enrollment in NanoLogix technology trial for detection of GBS in pregnant women

NanoLogix, an innovator in the accelerated detection and identification of microorganisms, announced today that the University of Texas Health Science Center in Houston is enrolling 300 patients in an ongoing clinical trial to study the speed and accuracy of NanoLogix technology. The trial is designed to compare NanoLogix technology to current methods in use for detection and identification of Group B Streptococcus (GBS) in pregnant women.

20 Oct 2010

EPO grants new patent to Silence Therapeutics’ RNAi structural modification technology

Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.

20 Oct 2010

Vitro signs contract with HemoGenix to manufacture, distribute stem cell analysis tools

Vitro Diagnostics, Inc., dba Vitro Biopharma, announced that it signed an amendment to its contract to jointly manufacture and distribute stem cell analysis tools with HemoGenix, Inc., a leading firm known for its pioneering HALO analysis platform for stem cells.

20 Oct 2010

MD Anderson treats lung cancer with pencil beam scanning proton therapy

Pencil beam scanning technology, an even more advanced and targeted form of radiation treatment known as proton therapy, is now being used to treat patients with lung cancer at The University of Texas MD Anderson Cancer Center.

20 Oct 2010

U-M hopes to make concept of recycling pacemakers a life-saving reality

Millions worldwide die each year because they can't afford a pacemaker. Meanwhile heart patients in the United States say they'd be willing to donate theirs after death to someone in need.

20 Oct 2010

MabCure announces agreement with Europe's medical centers to explore diagnostic test for ovarian cancer

Biotechnology company MabCure, Inc. today announced that it has signed a collaboration agreement with Catholic University, K.U. Leuven and University Hospital, UZ Leuven, Belgium, together comprising one of the largest and most reputable medical centers in Europe.

20 Oct 2010

Sysmex America enters contract agreement with Amerinet

Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced a three-year, dual source hematology contract agreement with Amerinet.

From Sysmex America, Inc. 20 Oct 2010

New book focuses on clinical importance of online HDF technique

Hemodiafiltration (HDF) for the treatment of end-stage renal disease patients is predominantly performed in European countries and in Japan, with some differences in technique such as rate of blood flow and dialysis fluid delivery systems.

20 Oct 2010

BIOTRONIK EHR DataSync software offers advanced patient management capabilities

BIOTRONIK SE Co. & KG, a leading manufacturer of implantable cardiac devices, has announced the European release of BIOTRONIK EHR DataSync. The software supports physicians, hospitals and clinics by integrating routine follow-up details, BIOTRONIK Home Monitoring remote follow-up information and data from the company's cardiac device programmers - ICS 3000 and the new programmer, Renamic, soon to be launched across Europe.

20 Oct 2010

New 3D Body Volume Index measurement calculates obesity risk

A new obesity measurement for the 21st Century, which can help identify individuals at risk of illness such as heart disease, strokes and diabetes, has been officially launched.

20 Oct 2010

Spectral commences pivotal Toraymyxin trial for severe sepsis

Spectral Diagnostics Inc., a Phase III company seeking FDA approval for its lead theranostics product for the treatment severe sepsis and septic shock, today announced initiation of its U.S. pivotal trial of Toraymyxin™, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream, for patients with severe sepsis.

20 Oct 2010

454 Life Sciences enters co-promotional agreement with Fluidigm

454 Life Sciences, a Roche Company, and Fluidigm Corporation announced today that they have entered a worldwide co-promotional agreement for the companies' complementary amplicon sample preparation and high-throughput sequencing platforms.

20 Oct 2010

State Roundup: Md.'s heath info exchange; LA to cut retiree health benefits; N.Y.'s mental health building boom

The Washington Post: "A Maryland health information exchange that will allow hospitals, physicians, labs and radiology centers to share patient information within the state went live last week. Three hospitals, three radiology centers, Quest Diagnostics and the Laboratory Corp. of America are already participating in the exchange."

20 Oct 2010

CIED implantation with AIGISRx Antibacterial Envelope reduces overall infection rate

Patients undergoing CIED (Cardiac Implantable Electronic Device) implantation with TYRX, Inc.'s FDA-cleared AIGISRx Antibacterial Envelope enjoyed a 99.5% rate of successful implantation with an overall infection rate of 0.48% in the first 1.9 months following the procedure, as reported in newly published results of TYRX's COMMAND Clinical Study.

20 Oct 2010

ThermoGenesis enters licensing agreement with BioParadox for Res-Q technology

ThermoGenesis Corp. a leading supplier of innovative products and services that process and store adult stem cells, said today it has entered into a license and distribution agreement for its Res-Q 60 BMC (Res-Q) System with BioParadox, Inc., a newly-formed regenerative medicine company focusing on point-of-care cardiovascular therapies.

20 Oct 2010

Agendia establishes contract with Humana for coverage of MammaPrint breast cancer recurrence test

Agendia, a world leader in molecular cancer diagnostics, announced today that it has established a contract with leading insurance provider Humana to reimburse for the company's MammaPrint test. Agendia's contract with Humana expands the coverage for MammaPrint by more than 17 million lives. In November 2009, Palmetto GBA, California's Part B Medicare administrator, established coding guidelines for MammaPrint, allowing healthcare providers from across the United States to submit claims for the test.

19 Oct 2010

Device / Technology News

First in vivo screening system for complete human nuclear hormone receptor family

Vivakor enters global licensing agreement with MIT Holding for Vivathermic Vials

Pharsight launches Phoenix Pharmacometric Productivity Challenge

Microsulis tissue ablation systems presented at London meeting

UTHSC-Houston initiates enrollment in NanoLogix technology trial for detection of GBS in pregnant women

EPO grants new patent to Silence Therapeutics’ RNAi structural modification technology

Vitro signs contract with HemoGenix to manufacture, distribute stem cell analysis tools

MD Anderson treats lung cancer with pencil beam scanning proton therapy

U-M hopes to make concept of recycling pacemakers a life-saving reality

MabCure announces agreement with Europe's medical centers to explore diagnostic test for ovarian cancer

Sysmex America enters contract agreement with Amerinet

New book focuses on clinical importance of online HDF technique

BIOTRONIK EHR DataSync software offers advanced patient management capabilities

New 3D Body Volume Index measurement calculates obesity risk

Spectral commences pivotal Toraymyxin trial for severe sepsis

454 Life Sciences enters co-promotional agreement with Fluidigm

State Roundup: Md.'s heath info exchange; LA to cut retiree health benefits; N.Y.'s mental health building boom

CIED implantation with AIGISRx Antibacterial Envelope reduces overall infection rate

ThermoGenesis enters licensing agreement with BioParadox for Res-Q technology

Agendia establishes contract with Humana for coverage of MammaPrint breast cancer recurrence test

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Latest News